Concepedia

Author

D S Goldstein

University of California Davis Medical Center

Also Known As

D S Goldstein, Desireé S. Goldstein

8

Publications

402

Citations

7

H-Index

22

Concepts

All Affiliations

University of California Davis Medical CenterUniversity of California, Davis
DS

About

D S Goldstein is an author at University of California Davis Medical Center specializing in medicine, oncology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

101

2

Immunology

2

2

65

3

Health Sciences

1

1

13

4

Emergency Medicine

1

1

23

5

Pathology

1

1

13

D S Goldstein

×

7

Publications

399

Citations

7

H-Index

YearCitations

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein,

Journal of Clinical Oncology

1998

182

Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody.

Sally J. DeNardo, L.F. O'Grady, Carol M. Richman,

PubMed

1997

60

Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.

Robert T. OʼDonnell, Sally J. DeNardo, A. Yuan,

PubMed

2001

56

Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.

Carol M. Richman, Sally J. DeNardo, Robert T. OʼDonnell,

PubMed

1999

37

67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.

Robert T. OʼDonnell, Gerald L. DeNardo, David L. Kukis,

PubMed

1999

28

Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.

D S Goldstein, M. Henry Williams

Thorax

1986

23

Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.

Gerald L. DeNardo, Kathleen R. Lamborn, Sally J. DeNardo,

PubMed

1995

13

Page 1